-
Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks' gestation.
Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH.
Fetal Diagn Ther 2011;30:274-9. -
First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein.
Bredaki FE, Wright D, Matos P, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011;30:215-8. -
Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women.
Bombard AT, Akolekar R, Farkas DH, Vanagtmael AL, Aquino F, Oeth P, Nicolaides KH.
Prenat Diagn 2011;31:802-8. -
Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks.
Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH.
Prenat Diagn 2011;31:75-83. -
Maternal serum a-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J, Bredaki FE, Calvo JR, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:88-93. -
Maternal serum progesterone-induced blocking factor at 11-13 weeks gestation in spontaneous early preterm delivery.
Beta J, Szekeres-Bartho J, Skyfta E, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;29:197-200. -
Maternal thyroid function at 11-13 weeks of gestation in fetal trisomies 21 and 18.
Ashoor G, Maiz N, Cuckle H, Jawdat F, Nicolaides KH.
Prenat Diagn 2011;31:33-7. -
Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery.
Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH.
Obstet Gynecol 2011;117:293-8. -
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH.
Prenat Diagn 2011;31:66-74. -
Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling.
Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH.
Prenat Diagn 2011;31:38-45. -
Maternal plasma plasminogen activator inhibitor-2 at 11 to 13 Weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Cruz JJ, Penco JM, Zhou Y, Nicolaides KH.
Hypertens Pregnancy 2011;30:194-202. -
Fetal RHD Genotyping in Maternal Plasma at 11-13 Weeks of Gestation.
Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH.
Fetal Diagn Ther 2011;29:301-6. -
Development of a training model for ultrasound-guided invasive procedures in fetal medicine.
Ville Y, Cooper M, Revel A, Frydman R, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:180-3. -
Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome.
Ville Y, Hyett J, Hecher K, Nicolaides KH.
N Engl J Med 1995;332:224-7. -
Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy.
Tsakonas DP, Nicolaides KH, Tsakona CP, Worman CP, Goldstone AH.
Clin Lab Haematol 1995;17:57-9. -
Neutrophil and monocyte beta 2-integrin expression in maternal and fetal blood.
Thilaganathan B, Makrydimas G, Plachouras N, Nicolaides KH.
Am J Obstet Gynecol 1995;172:58-62. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Blood transferrin receptor expression in chromosomally abnormal fetuses.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:282-4. -
Fetal oxygenation at cordocentesis, maternal smoking and childhood neuro-development.
Soothill PW, Ajayi RA, Campbell S, Ross EM, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 1995;59:21-4. -
Prevalence of fetal facial cleft at different stages of pregnancy.
Snijders RJ, Sebire NJ, Psara N, Souka A, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:327-9.